Cyberonics Not Banking On Expanded VNS Therapy Coverage In 2006
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics projects no further coverage decisions in 2006 for its VNS Therapy for treatment-resistant depression (TRD) and has lowered its revenue projections accordingly